Rajasthan suspends 215 pharmacies under RGHS
Analysis based on 7 articles · First reported Aug 26, 2026 · Last updated Aug 26, 2026
The suspension of 215 private pharmacies under RGHS may disrupt medicine distribution for beneficiaries in India — Rajasthan, potentially affecting the operations and revenues of the involved pharmacies. The regulatory action signals stricter enforcement of healthcare scheme compliance, which could influence investor sentiment toward pharmaceutical retail and healthcare services in the region.
The India — Rajasthan government temporarily suspended the Transaction Management System (TMS) of 215 private pharmacies under the India — Rajasthan Health Department (RGHS) for allegedly failing to provide medicines to beneficiaries or operate under the scheme for nearly two months. The action followed directives from Chief Minister Bhajan Lal Sharma and Medical and Health Minister Gajendra Singh Khimsar to ensure timely availability of medicines. Principal Secretary Gayatri Rathore stated that pharmacies were issued show-cause notices and given an opportunity to explain; TMS access was suspended after responses were unsatisfactory or absent. The highest number of suspensions occurred in India — Jaipur (39), followed by India — Alwar and India — Sikar (20 each), India — Bharatpur, India — Churu, and India — Dausa (10 each), and others across the state, including two pharmacies outside India — Rajasthan in India — Delhi and India — Gurgaon. RGHS Project Director Nidhi Patel emphasized that negligence or delays in medicine distribution are treated seriously, and further action will be taken after reviewing explanations and records.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard